9PAZ | pdb_00009paz

Solution NMR structure of conotoxin AoIA


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 50 
  • Conformers Submitted: 20 
  • Selection Criteria: Molprobity score 

wwPDB Validation 3D Report Full Report

Validation slider image for 9PAZ

This is version 1.1 of the entry. See complete history

Literature

Structural and functional basis of antinociceptive action of chi-conotoxin AoIA at the noradrenaline transporter.

Belleza, O.J.V.Zhang, H.Schmidhammer, H.Gonzalez, T.I.Ciotu, C.I.Tomasevic, N.Ocampo, C.M.M.Fernando, J.C.Koehbach, J.Schwarz, P.Al Makhlouf, M.Tajti, G.Hasinger, S.Kastner, N.Avsar, O.Retzl, B.Jantsch, K.Jiang, Y.Hellinger, R.Fischer, M.J.M.Rosengren, K.J.Gruber, C.W.Villaraza, A.J.L.Stockner, T.Spetea, M.Xu, H.E.Sitte, H.H.

(2026) Nat Struct Mol Biol 

  • DOI: https://doi.org/10.1038/s41594-026-01838-z
  • Primary Citation Related Structures: 
    9K6X, 9PAZ, 9PB0

  • PubMed Abstract: 

    The χ-conotoxins are venom-derived peptides that specifically target the noradrenaline transporter (also known as norepinephrine transporter, NET). Regulation of noradrenergic signaling by NET affects neurophysiological processes, including pain. Therefore, the χ-conotoxin MrIA and its synthetic analogs have been previously investigated for their analgesic activity. Here we describe the synthesis and pharmacological characterization of χ-AoIA, a peptide that selectively inhibits NET with a higher potency compared to MrIA in in vitro radiotracer flux assays. Furthermore, we resolved the structure of the human NET:χ-AoIA complex by cryogenic electron microscopy, which revealed an atypical binding mode consisting of both the central binding site and the outer vestibule of the transporter. Lastly, χ-AoIA displays antinociceptive efficacy in a model of inflammatory pain after subcutaneous administration in mice. Our results demonstrate the efficacy of χ-AoIA as a highly selective ligand of NET and provide a mechanistic basis for its potential development as a nonopioid analgesic.


  • Organizational Affiliation
    • Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.

Macromolecule Content 

  • Total Structure Weight: 1.32 kDa 
  • Atom Count: 87 
  • Modeled Residue Count: 11 
  • Deposited Residue Count: 11 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Chi-conotoxin-like Ar131111Conus araneosusMutation(s): 0 
UniProt
Find proteins for P0CI23 (Conus araneosus)
Explore P0CI23 
Go to UniProtKB:  P0CI23
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP0CI23
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Modified Residues  1 Unique
IDChains TypeFormula2D DiagramParent
HYP
Query on HYP
A
L-PEPTIDE LINKINGC5 H9 N O3PRO

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 50 
  • Conformers Submitted: 20 
  • Selection Criteria: Molprobity score 

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Australian Research Council (ARC)Australia--

Revision History  (Full details and data files)

  • Version 1.0: 2026-07-29
    Type: Initial release
  • Version 1.1: 2026-08-05
    Changes: Database references